Advertisement

Topics

Alexo Therapeutics Initiates ALX148 Clinical Trial Combination Cohorts for the Treatment of Patients with Advanced Solid Tumors and Lymphoma

06:00 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Updated Clinical Data Will Be Presented at the 2018 American Society of Clinical Oncology Annual Meeting (ASCO) Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 check...

Other Sources for this Article

MacDougall Biomedical Communications
Karen Sharma or Shai Biran, Ph.D., 781-235-3060
alexo@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "Alexo Therapeutics Initiates ALX148 Clinical Trial Combination Cohorts for the Treatment of Patients with Advanced Solid Tumors and Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...